nodes	percent_of_prediction	percent_of_DWPC	metapath
Remoxipride—HTR2A—enteric nervous system—Crohn's disease	0.395	0.428	CbGeAlD
Remoxipride—HTR2A—myenteric nerve plexus—Crohn's disease	0.299	0.324	CbGeAlD
Remoxipride—SIGMAR1—smooth muscle tissue—Crohn's disease	0.0539	0.0584	CbGeAlD
Remoxipride—SIGMAR1—mammalian vulva—Crohn's disease	0.0485	0.0526	CbGeAlD
Remoxipride—HTR2A—epithelium—Crohn's disease	0.0298	0.0323	CbGeAlD
Remoxipride—HTR2A—smooth muscle tissue—Crohn's disease	0.0287	0.0311	CbGeAlD
Remoxipride—SIGMAR1—lymph node—Crohn's disease	0.0243	0.0263	CbGeAlD
Remoxipride—HTR2A—digestive system—Crohn's disease	0.0227	0.0246	CbGeAlD
Remoxipride—CYP2D6—digestive system—Crohn's disease	0.0206	0.0224	CbGeAlD
Remoxipride—DRD2—GPCRs, Class A Rhodopsin-like—GPR65—Crohn's disease	0.000489	0.0063	CbGpPWpGaD
Remoxipride—HTR2A—GPCR ligand binding—MLN—Crohn's disease	0.000487	0.00627	CbGpPWpGaD
Remoxipride—HTR2A—GPCRs, Class A Rhodopsin-like—GPR65—Crohn's disease	0.000481	0.0062	CbGpPWpGaD
Remoxipride—DRD4—GPCR ligand binding—GPR65—Crohn's disease	0.000469	0.00604	CbGpPWpGaD
Remoxipride—DRD3—GPCRs, Class A Rhodopsin-like—CCR6—Crohn's disease	0.000455	0.00586	CbGpPWpGaD
Remoxipride—DRD4—GPCRs, Class A Rhodopsin-like—PTGER4—Crohn's disease	0.000451	0.00581	CbGpPWpGaD
Remoxipride—DRD2—Class A/1 (Rhodopsin-like receptors)—CCR9—Crohn's disease	0.00045	0.0058	CbGpPWpGaD
Remoxipride—DRD3—GPCR ligand binding—CCR9—Crohn's disease	0.000448	0.00577	CbGpPWpGaD
Remoxipride—HTR2A—Class A/1 (Rhodopsin-like receptors)—CCR9—Crohn's disease	0.000443	0.00571	CbGpPWpGaD
Remoxipride—DRD4—Class A/1 (Rhodopsin-like receptors)—CCR6—Crohn's disease	0.000439	0.00566	CbGpPWpGaD
Remoxipride—DRD2—Class A/1 (Rhodopsin-like receptors)—GPR65—Crohn's disease	0.000419	0.00539	CbGpPWpGaD
Remoxipride—DRD3—GPCR ligand binding—GPR65—Crohn's disease	0.000417	0.00537	CbGpPWpGaD
Remoxipride—HTR2A—Class A/1 (Rhodopsin-like receptors)—GPR65—Crohn's disease	0.000412	0.00531	CbGpPWpGaD
Remoxipride—DRD4—GPCR downstream signaling—MLN—Crohn's disease	0.000411	0.0053	CbGpPWpGaD
Remoxipride—DRD3—GPCRs, Class A Rhodopsin-like—PTGER4—Crohn's disease	0.0004	0.00516	CbGpPWpGaD
Remoxipride—DRD4—Signaling by GPCR—ACKR2—Crohn's disease	0.000394	0.00508	CbGpPWpGaD
Remoxipride—DRD3—Class A/1 (Rhodopsin-like receptors)—CCR6—Crohn's disease	0.00039	0.00502	CbGpPWpGaD
Remoxipride—DRD4—Class A/1 (Rhodopsin-like receptors)—PTGER4—Crohn's disease	0.000386	0.00498	CbGpPWpGaD
Remoxipride—DRD2—G alpha (i) signalling events—CCR6—Crohn's disease	0.000375	0.00483	CbGpPWpGaD
Remoxipride—DRD4—Signaling by GPCR—MLN—Crohn's disease	0.000373	0.00481	CbGpPWpGaD
Remoxipride—DRD3—GPCR downstream signaling—MLN—Crohn's disease	0.000365	0.00471	CbGpPWpGaD
Remoxipride—DRD3—Signaling by GPCR—ACKR2—Crohn's disease	0.00035	0.00451	CbGpPWpGaD
Remoxipride—DRD2—GPCRs, Class A Rhodopsin-like—CCR6—Crohn's disease	0.000348	0.00449	CbGpPWpGaD
Remoxipride—DRD3—Class A/1 (Rhodopsin-like receptors)—PTGER4—Crohn's disease	0.000343	0.00442	CbGpPWpGaD
Remoxipride—DRD2—GPCR ligand binding—CCR9—Crohn's disease	0.000343	0.00442	CbGpPWpGaD
Remoxipride—HTR2A—GPCRs, Class A Rhodopsin-like—CCR6—Crohn's disease	0.000342	0.00441	CbGpPWpGaD
Remoxipride—CYP2D6—Metapathway biotransformation—GPX4—Crohn's disease	0.000342	0.00441	CbGpPWpGaD
Remoxipride—HTR2A—GPCR ligand binding—CCR9—Crohn's disease	0.000337	0.00435	CbGpPWpGaD
Remoxipride—DRD4—GPCR ligand binding—CCR6—Crohn's disease	0.000334	0.00431	CbGpPWpGaD
Remoxipride—DRD3—Signaling by GPCR—MLN—Crohn's disease	0.000332	0.00428	CbGpPWpGaD
Remoxipride—HTR2A—G alpha (q) signalling events—RASGRP1—Crohn's disease	0.000321	0.00414	CbGpPWpGaD
Remoxipride—DRD2—GPCR ligand binding—GPR65—Crohn's disease	0.000319	0.00411	CbGpPWpGaD
Remoxipride—HTR2A—GPCR ligand binding—GPR65—Crohn's disease	0.000314	0.00404	CbGpPWpGaD
Remoxipride—DRD2—GPCRs, Class A Rhodopsin-like—PTGER4—Crohn's disease	0.000306	0.00395	CbGpPWpGaD
Remoxipride—HTR2A—SIDS Susceptibility Pathways—IL10—Crohn's disease	0.000302	0.00389	CbGpPWpGaD
Remoxipride—HTR2A—GPCRs, Class A Rhodopsin-like—PTGER4—Crohn's disease	0.000302	0.00389	CbGpPWpGaD
Remoxipride—DRD2—Class A/1 (Rhodopsin-like receptors)—CCR6—Crohn's disease	0.000298	0.00384	CbGpPWpGaD
Remoxipride—DRD3—GPCR ligand binding—CCR6—Crohn's disease	0.000297	0.00383	CbGpPWpGaD
Remoxipride—DRD4—GPCR ligand binding—PTGER4—Crohn's disease	0.000294	0.00379	CbGpPWpGaD
Remoxipride—HTR2A—Class A/1 (Rhodopsin-like receptors)—CCR6—Crohn's disease	0.000293	0.00378	CbGpPWpGaD
Remoxipride—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—RASGRP1—Crohn's disease	0.000287	0.0037	CbGpPWpGaD
Remoxipride—DRD4—GPCR downstream signaling—CCR9—Crohn's disease	0.000285	0.00367	CbGpPWpGaD
Remoxipride—DRD2—GPCR downstream signaling—MLN—Crohn's disease	0.00028	0.0036	CbGpPWpGaD
Remoxipride—HTR2A—GPCR downstream signaling—MLN—Crohn's disease	0.000275	0.00354	CbGpPWpGaD
Remoxipride—DRD2—Signaling by GPCR—ACKR2—Crohn's disease	0.000268	0.00345	CbGpPWpGaD
Remoxipride—DRD4—GPCR downstream signaling—GPR65—Crohn's disease	0.000265	0.00342	CbGpPWpGaD
Remoxipride—HTR2A—Signaling by GPCR—ACKR2—Crohn's disease	0.000263	0.0034	CbGpPWpGaD
Remoxipride—DRD2—Class A/1 (Rhodopsin-like receptors)—PTGER4—Crohn's disease	0.000263	0.00338	CbGpPWpGaD
Remoxipride—DRD3—GPCR ligand binding—PTGER4—Crohn's disease	0.000261	0.00337	CbGpPWpGaD
Remoxipride—DRD4—Signaling by GPCR—CCR9—Crohn's disease	0.000259	0.00334	CbGpPWpGaD
Remoxipride—HTR2A—Class A/1 (Rhodopsin-like receptors)—PTGER4—Crohn's disease	0.000258	0.00333	CbGpPWpGaD
Remoxipride—DRD2—Signaling by GPCR—MLN—Crohn's disease	0.000254	0.00327	CbGpPWpGaD
Remoxipride—DRD3—GPCR downstream signaling—CCR9—Crohn's disease	0.000253	0.00326	CbGpPWpGaD
Remoxipride—HTR2A—Signaling by GPCR—MLN—Crohn's disease	0.00025	0.00322	CbGpPWpGaD
Remoxipride—DRD4—Signaling by GPCR—GPR65—Crohn's disease	0.000241	0.0031	CbGpPWpGaD
Remoxipride—DRD3—GPCR downstream signaling—GPR65—Crohn's disease	0.000235	0.00303	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—ACKR2—Crohn's disease	0.000233	0.003	CbGpPWpGaD
Remoxipride—DRD3—Signaling by GPCR—CCR9—Crohn's disease	0.00023	0.00296	CbGpPWpGaD
Remoxipride—DRD2—GPCR ligand binding—CCR6—Crohn's disease	0.000227	0.00293	CbGpPWpGaD
Remoxipride—HTR2A—GPCR ligand binding—CCR6—Crohn's disease	0.000223	0.00288	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—MLN—Crohn's disease	0.000221	0.00284	CbGpPWpGaD
Remoxipride—DRD3—Signaling by GPCR—GPR65—Crohn's disease	0.000214	0.00276	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—ACKR2—Crohn's disease	0.000207	0.00266	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—TAGAP—Crohn's disease	0.000202	0.0026	CbGpPWpGaD
Remoxipride—DRD2—GPCR ligand binding—PTGER4—Crohn's disease	0.0002	0.00258	CbGpPWpGaD
Remoxipride—HTR2A—GPCR ligand binding—PTGER4—Crohn's disease	0.000197	0.00254	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—MLN—Crohn's disease	0.000196	0.00253	CbGpPWpGaD
Remoxipride—DRD2—GPCR downstream signaling—CCR9—Crohn's disease	0.000194	0.0025	CbGpPWpGaD
Remoxipride—HTR2A—GPCR downstream signaling—CCR9—Crohn's disease	0.000191	0.00246	CbGpPWpGaD
Remoxipride—DRD4—GPCR downstream signaling—CCR6—Crohn's disease	0.000189	0.00243	CbGpPWpGaD
Remoxipride—DRD2—GPCR downstream signaling—GPR65—Crohn's disease	0.00018	0.00232	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—TAGAP—Crohn's disease	0.000179	0.00231	CbGpPWpGaD
Remoxipride—DRD4—G alpha (i) signalling events—CXCL8—Crohn's disease	0.000178	0.00229	CbGpPWpGaD
Remoxipride—HTR2A—GPCR downstream signaling—GPR65—Crohn's disease	0.000177	0.00228	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—RSPO3—Crohn's disease	0.000176	0.00227	CbGpPWpGaD
Remoxipride—DRD2—Signaling by GPCR—CCR9—Crohn's disease	0.000176	0.00227	CbGpPWpGaD
Remoxipride—HTR2A—Signaling by GPCR—CCR9—Crohn's disease	0.000173	0.00223	CbGpPWpGaD
Remoxipride—DRD4—Signaling by GPCR—CCR6—Crohn's disease	0.000171	0.00221	CbGpPWpGaD
Remoxipride—DRD3—GPCR downstream signaling—CCR6—Crohn's disease	0.000168	0.00216	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—SEL1L—Crohn's disease	0.000167	0.00215	CbGpPWpGaD
Remoxipride—DRD4—GPCR downstream signaling—PTGER4—Crohn's disease	0.000166	0.00214	CbGpPWpGaD
Remoxipride—HTR2A—SIDS Susceptibility Pathways—CXCL8—Crohn's disease	0.000165	0.00213	CbGpPWpGaD
Remoxipride—DRD2—Signaling by GPCR—GPR65—Crohn's disease	0.000164	0.00211	CbGpPWpGaD
Remoxipride—HTR2A—Signaling by GPCR—GPR65—Crohn's disease	0.000161	0.00207	CbGpPWpGaD
Remoxipride—HTR2A—SIDS Susceptibility Pathways—IL1B—Crohn's disease	0.000158	0.00204	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—ACKR2—Crohn's disease	0.000158	0.00204	CbGpPWpGaD
Remoxipride—DRD3—G alpha (i) signalling events—CXCL8—Crohn's disease	0.000158	0.00204	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—RSPO3—Crohn's disease	0.000157	0.00202	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—ACKR2—Crohn's disease	0.000156	0.00201	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—CCR9—Crohn's disease	0.000153	0.00197	CbGpPWpGaD
Remoxipride—DRD3—Signaling by GPCR—CCR6—Crohn's disease	0.000152	0.00196	CbGpPWpGaD
Remoxipride—DRD4—Signaling by GPCR—PTGER4—Crohn's disease	0.000151	0.00195	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—MLN—Crohn's disease	0.00015	0.00193	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—SEL1L—Crohn's disease	0.000149	0.00191	CbGpPWpGaD
Remoxipride—DRD3—GPCR downstream signaling—PTGER4—Crohn's disease	0.000148	0.0019	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—MLN—Crohn's disease	0.000148	0.0019	CbGpPWpGaD
Remoxipride—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—Crohn's disease	0.000147	0.00189	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—GPR65—Crohn's disease	0.000142	0.00183	CbGpPWpGaD
Remoxipride—DRD4—GPCR downstream signaling—IL3—Crohn's disease	0.000142	0.00183	CbGpPWpGaD
Remoxipride—DRD4—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	0.000141	0.00182	CbGpPWpGaD
Remoxipride—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—JAK2—Crohn's disease	0.00014	0.0018	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—TAGAP—Crohn's disease	0.000137	0.00177	CbGpPWpGaD
Remoxipride—DRD4—GPCR downstream signaling—RASGRP1—Crohn's disease	0.000137	0.00177	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—CCR9—Crohn's disease	0.000136	0.00175	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—TAGAP—Crohn's disease	0.000135	0.00174	CbGpPWpGaD
Remoxipride—DRD3—Signaling by GPCR—PTGER4—Crohn's disease	0.000134	0.00173	CbGpPWpGaD
Remoxipride—DRD4—Signaling by GPCR—IL3—Crohn's disease	0.000129	0.00166	CbGpPWpGaD
Remoxipride—DRD2—GPCR downstream signaling—CCR6—Crohn's disease	0.000128	0.00165	CbGpPWpGaD
Remoxipride—HTR2A—GPCR downstream signaling—CCR6—Crohn's disease	0.000126	0.00163	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—GPR65—Crohn's disease	0.000126	0.00163	CbGpPWpGaD
Remoxipride—DRD3—GPCR downstream signaling—IL3—Crohn's disease	0.000126	0.00162	CbGpPWpGaD
Remoxipride—DRD3—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	0.000126	0.00162	CbGpPWpGaD
Remoxipride—DRD4—Signaling by GPCR—RASGRP1—Crohn's disease	0.000124	0.0016	CbGpPWpGaD
Remoxipride—DRD3—GPCR downstream signaling—RASGRP1—Crohn's disease	0.000122	0.00157	CbGpPWpGaD
Remoxipride—DRD2—G alpha (i) signalling events—CXCL8—Crohn's disease	0.000121	0.00156	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—RSPO3—Crohn's disease	0.00012	0.00155	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—RSPO3—Crohn's disease	0.000118	0.00152	CbGpPWpGaD
Remoxipride—DRD2—Signaling by GPCR—CCR6—Crohn's disease	0.000117	0.0015	CbGpPWpGaD
Remoxipride—HTR2A—SIDS Susceptibility Pathways—TNF—Crohn's disease	0.000115	0.00148	CbGpPWpGaD
Remoxipride—HTR2A—Signaling by GPCR—CCR6—Crohn's disease	0.000115	0.00148	CbGpPWpGaD
Remoxipride—DRD3—Signaling by GPCR—IL3—Crohn's disease	0.000114	0.00147	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—SEL1L—Crohn's disease	0.000114	0.00146	CbGpPWpGaD
Remoxipride—DRD4—Circadian rythm related genes—IL6—Crohn's disease	0.000113	0.00146	CbGpPWpGaD
Remoxipride—DRD2—GPCR downstream signaling—PTGER4—Crohn's disease	0.000113	0.00146	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—SEL1L—Crohn's disease	0.000112	0.00144	CbGpPWpGaD
Remoxipride—HTR2A—GPCR downstream signaling—PTGER4—Crohn's disease	0.000111	0.00143	CbGpPWpGaD
Remoxipride—DRD3—Signaling by GPCR—RASGRP1—Crohn's disease	0.00011	0.00142	CbGpPWpGaD
Remoxipride—DRD4—GPCR ligand binding—CXCL8—Crohn's disease	0.000108	0.00139	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—CCR9—Crohn's disease	0.000104	0.00134	CbGpPWpGaD
Remoxipride—DRD2—Signaling by GPCR—PTGER4—Crohn's disease	0.000103	0.00132	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—CCR9—Crohn's disease	0.000102	0.00132	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—CCR6—Crohn's disease	0.000101	0.00131	CbGpPWpGaD
Remoxipride—HTR2A—Signaling by GPCR—PTGER4—Crohn's disease	0.000101	0.0013	CbGpPWpGaD
Remoxipride—DRD3—Circadian rythm related genes—IL6—Crohn's disease	0.000101	0.0013	CbGpPWpGaD
Remoxipride—DRD4—GPCR downstream signaling—IL2RA—Crohn's disease	9.92e-05	0.00128	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—GPR65—Crohn's disease	9.66e-05	0.00125	CbGpPWpGaD
Remoxipride—DRD2—GPCR downstream signaling—IL3—Crohn's disease	9.62e-05	0.00124	CbGpPWpGaD
Remoxipride—DRD2—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	9.61e-05	0.00124	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—PLA2G4F—Crohn's disease	9.57e-05	0.00123	CbGpPWpGaD
Remoxipride—DRD3—GPCR ligand binding—CXCL8—Crohn's disease	9.56e-05	0.00123	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—GPR65—Crohn's disease	9.51e-05	0.00123	CbGpPWpGaD
Remoxipride—HTR2A—GPCR downstream signaling—IL3—Crohn's disease	9.47e-05	0.00122	CbGpPWpGaD
Remoxipride—HTR2A—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	9.46e-05	0.00122	CbGpPWpGaD
Remoxipride—DRD2—GPCR downstream signaling—RASGRP1—Crohn's disease	9.31e-05	0.0012	CbGpPWpGaD
Remoxipride—HTR2A—SIDS Susceptibility Pathways—IL6—Crohn's disease	9.27e-05	0.0012	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—RBX1—Crohn's disease	9.16e-05	0.00118	CbGpPWpGaD
Remoxipride—HTR2A—GPCR downstream signaling—RASGRP1—Crohn's disease	9.16e-05	0.00118	CbGpPWpGaD
Remoxipride—DRD4—Signaling by GPCR—IL2RA—Crohn's disease	9.01e-05	0.00116	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—CCR6—Crohn's disease	9e-05	0.00116	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—PTGER4—Crohn's disease	8.92e-05	0.00115	CbGpPWpGaD
Remoxipride—DRD3—GPCR downstream signaling—IL2RA—Crohn's disease	8.81e-05	0.00114	CbGpPWpGaD
Remoxipride—DRD2—Signaling by GPCR—IL3—Crohn's disease	8.74e-05	0.00113	CbGpPWpGaD
Remoxipride—HTR2A—Signaling by GPCR—IL3—Crohn's disease	8.6e-05	0.00111	CbGpPWpGaD
Remoxipride—DRD2—Signaling by GPCR—RASGRP1—Crohn's disease	8.45e-05	0.00109	CbGpPWpGaD
Remoxipride—HTR2A—Signaling by GPCR—RASGRP1—Crohn's disease	8.32e-05	0.00107	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—RBX1—Crohn's disease	8.14e-05	0.00105	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—MTMR3—Crohn's disease	8.13e-05	0.00105	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—UBE2D1—Crohn's disease	8.03e-05	0.00104	CbGpPWpGaD
Remoxipride—DRD3—Signaling by GPCR—IL2RA—Crohn's disease	8e-05	0.00103	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—PTGER4—Crohn's disease	7.92e-05	0.00102	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—RIPK2—Crohn's disease	7.79e-05	0.001	CbGpPWpGaD
Remoxipride—DRD2—Circadian rythm related genes—IL6—Crohn's disease	7.69e-05	0.000992	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—IL3—Crohn's disease	7.6e-05	0.000979	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—RASGRP1—Crohn's disease	7.35e-05	0.000947	CbGpPWpGaD
Remoxipride—DRD2—GPCR ligand binding—CXCL8—Crohn's disease	7.32e-05	0.000943	CbGpPWpGaD
Remoxipride—HTR2A—GPCR ligand binding—CXCL8—Crohn's disease	7.2e-05	0.000928	CbGpPWpGaD
Remoxipride—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Crohn's disease	7.17e-05	0.000925	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—UBE2D1—Crohn's disease	7.13e-05	0.00092	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—RIPK2—Crohn's disease	6.92e-05	0.000892	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—CCR6—Crohn's disease	6.88e-05	0.000887	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—CCR6—Crohn's disease	6.77e-05	0.000873	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—IL3—Crohn's disease	6.75e-05	0.00087	CbGpPWpGaD
Remoxipride—DRD2—GPCR downstream signaling—IL2RA—Crohn's disease	6.74e-05	0.000869	CbGpPWpGaD
Remoxipride—DRD4—GPCR downstream signaling—JAK2—Crohn's disease	6.67e-05	0.000859	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—SOCS1—Crohn's disease	6.66e-05	0.000858	CbGpPWpGaD
Remoxipride—HTR2A—GPCR downstream signaling—IL2RA—Crohn's disease	6.63e-05	0.000855	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—RASGRP1—Crohn's disease	6.53e-05	0.000841	CbGpPWpGaD
Remoxipride—DRD4—Signaling by GPCR—TYK2—Crohn's disease	6.35e-05	0.000818	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—FADS1—Crohn's disease	6.34e-05	0.000817	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—RBX1—Crohn's disease	6.23e-05	0.000803	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—RBX1—Crohn's disease	6.13e-05	0.00079	CbGpPWpGaD
Remoxipride—DRD2—Signaling by GPCR—IL2RA—Crohn's disease	6.12e-05	0.000789	CbGpPWpGaD
Remoxipride—DRD4—GPCR downstream signaling—CXCL8—Crohn's disease	6.08e-05	0.000784	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—PTGER4—Crohn's disease	6.06e-05	0.000781	CbGpPWpGaD
Remoxipride—DRD4—Signaling by GPCR—JAK2—Crohn's disease	6.05e-05	0.00078	CbGpPWpGaD
Remoxipride—HTR2A—Signaling by GPCR—IL2RA—Crohn's disease	6.02e-05	0.000776	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—PTGER4—Crohn's disease	5.96e-05	0.000769	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—GPX4—Crohn's disease	5.93e-05	0.000765	CbGpPWpGaD
Remoxipride—DRD3—GPCR downstream signaling—JAK2—Crohn's disease	5.92e-05	0.000763	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—SOCS1—Crohn's disease	5.91e-05	0.000762	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—SMAD3—Crohn's disease	5.75e-05	0.000741	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—GCKR—Crohn's disease	5.73e-05	0.000739	CbGpPWpGaD
Remoxipride—DRD3—Signaling by GPCR—TYK2—Crohn's disease	5.64e-05	0.000727	CbGpPWpGaD
Remoxipride—DRD4—Signaling by GPCR—CXCL8—Crohn's disease	5.53e-05	0.000712	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—UBE2D1—Crohn's disease	5.46e-05	0.000704	CbGpPWpGaD
Remoxipride—DRD3—GPCR downstream signaling—CXCL8—Crohn's disease	5.4e-05	0.000697	CbGpPWpGaD
Remoxipride—DRD3—Signaling by GPCR—JAK2—Crohn's disease	5.38e-05	0.000693	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—UBE2D1—Crohn's disease	5.37e-05	0.000692	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—IL2RA—Crohn's disease	5.32e-05	0.000686	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—RIPK2—Crohn's disease	5.29e-05	0.000682	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—RIPK2—Crohn's disease	5.21e-05	0.000671	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—IL3—Crohn's disease	5.16e-05	0.000665	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—SMAD3—Crohn's disease	5.1e-05	0.000658	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—IL3—Crohn's disease	5.08e-05	0.000655	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—RASGRP1—Crohn's disease	4.99e-05	0.000644	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—RASGRP1—Crohn's disease	4.91e-05	0.000633	CbGpPWpGaD
Remoxipride—DRD3—Signaling by GPCR—CXCL8—Crohn's disease	4.91e-05	0.000633	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—IL2RA—Crohn's disease	4.73e-05	0.000609	CbGpPWpGaD
Remoxipride—DRD2—GPCR downstream signaling—JAK2—Crohn's disease	4.53e-05	0.000584	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—SOCS1—Crohn's disease	4.52e-05	0.000583	CbGpPWpGaD
Remoxipride—HTR2A—GPCR downstream signaling—JAK2—Crohn's disease	4.46e-05	0.000575	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—SOCS1—Crohn's disease	4.45e-05	0.000574	CbGpPWpGaD
Remoxipride—DRD2—Signaling by GPCR—TYK2—Crohn's disease	4.31e-05	0.000556	CbGpPWpGaD
Remoxipride—HTR2A—Signaling by GPCR—TYK2—Crohn's disease	4.24e-05	0.000547	CbGpPWpGaD
Remoxipride—DRD2—GPCR downstream signaling—CXCL8—Crohn's disease	4.14e-05	0.000533	CbGpPWpGaD
Remoxipride—DRD2—Signaling by GPCR—JAK2—Crohn's disease	4.11e-05	0.00053	CbGpPWpGaD
Remoxipride—HTR2A—GPCR downstream signaling—CXCL8—Crohn's disease	4.07e-05	0.000524	CbGpPWpGaD
Remoxipride—HTR2A—Signaling by GPCR—JAK2—Crohn's disease	4.05e-05	0.000522	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—SMAD3—Crohn's disease	3.91e-05	0.000503	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—SMAD3—Crohn's disease	3.84e-05	0.000495	CbGpPWpGaD
Remoxipride—DRD2—Signaling by GPCR—CXCL8—Crohn's disease	3.76e-05	0.000484	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—TYK2—Crohn's disease	3.75e-05	0.000483	CbGpPWpGaD
Remoxipride—HTR2A—Signaling by GPCR—CXCL8—Crohn's disease	3.7e-05	0.000476	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—IL2RA—Crohn's disease	3.62e-05	0.000466	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—JAK2—Crohn's disease	3.58e-05	0.000461	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—IL2RA—Crohn's disease	3.56e-05	0.000459	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—TYK2—Crohn's disease	3.33e-05	0.000429	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—CXCL8—Crohn's disease	3.26e-05	0.000421	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—JAK2—Crohn's disease	3.18e-05	0.000409	CbGpPWpGaD
Remoxipride—DRD4—Signaling by GPCR—IL6—Crohn's disease	3.1e-05	0.0004	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—CXCL8—Crohn's disease	2.9e-05	0.000374	CbGpPWpGaD
Remoxipride—DRD3—Signaling by GPCR—IL6—Crohn's disease	2.76e-05	0.000355	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—STAT3—Crohn's disease	2.62e-05	0.000338	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—TYK2—Crohn's disease	2.55e-05	0.000328	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—TYK2—Crohn's disease	2.51e-05	0.000323	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—JAK2—Crohn's disease	2.43e-05	0.000313	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—JAK2—Crohn's disease	2.39e-05	0.000308	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—STAT3—Crohn's disease	2.33e-05	0.000301	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—CXCL8—Crohn's disease	2.22e-05	0.000286	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—CXCL8—Crohn's disease	2.18e-05	0.000281	CbGpPWpGaD
Remoxipride—DRD2—Signaling by GPCR—IL6—Crohn's disease	2.11e-05	0.000272	CbGpPWpGaD
Remoxipride—HTR2A—Signaling by GPCR—IL6—Crohn's disease	2.08e-05	0.000268	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—IL6—Crohn's disease	1.83e-05	0.000236	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—ALB—Crohn's disease	1.82e-05	0.000235	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—STAT3—Crohn's disease	1.78e-05	0.00023	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—STAT3—Crohn's disease	1.76e-05	0.000226	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—IL6—Crohn's disease	1.63e-05	0.00021	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—PTGS2—Crohn's disease	1.6e-05	0.000206	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—IL6—Crohn's disease	1.25e-05	0.000161	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—IL6—Crohn's disease	1.23e-05	0.000158	CbGpPWpGaD
